NeuroMetrix, Inc. Files For China Approval Of Peripheral Neuropathy Test

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NeuroMetrix, a Massachusetts maker of medical devices, has filed for China approval of its point-of-care testing device for diabetic peripheral neuropathy, NC-stat® DPNCheck®. Omron Healthcare, a Japanese company that is NeuroMetrix’ partner for China and Asia, collaborated on the submission. The two companies completed a similar filing in Japan earlier this year.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC